Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


06.08.2018

1 Ann Oncol
1 Ann Surg Oncol
6 Anticancer Res
1 BMC Cancer
1 BMC Gastroenterol
1 Br J Cancer
1 Cancer Lett
1 Eur J Cancer
5 Eur J Surg Oncol
3 Gastroenterology
1 Hum Pathol
6 Int J Colorectal Dis
5 Int J Oncol
1 Lancet
3 Oncol Rep
4 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Ann Oncol

  1. MAURI G, Bencardino K, Sartore-Bianchi A, Siena S, et al
    Toxicity of oxaliplatin rechallenge in metastatic colorectal cancer.
    Ann Oncol. 2018 Jul 28. pii: 5061139. doi: 10.1093.
    PubMed     Text format    


    Ann Surg Oncol

  2. LEE DW, Han SW, Kang JK, Bae JM, et al
    Association Between Fusobacterium nucleatum, Pathway Mutation, and Patient Prognosis in Colorectal Cancer.
    Ann Surg Oncol. 2018 Jul 30. pii: 10.1245/s10434-018-6681.
    PubMed     Text format     Abstract available


    Anticancer Res

  3. HIRAYAMA K, Sudoh M, Shimizu H, Furuya S, et al
    Clinical Impact of Histological Heterogeneity in the Metastatic Lymph Nodes of Patients with Colorectal Cancer.
    Anticancer Res. 2018;38:4797-4803.
    PubMed     Text format     Abstract available

  4. DAITOKU N, Miyamoto Y, Tokunaga R, Sakamoto Y, et al
    Controlling Nutritional Status (CONUT) Score Is a Prognostic Marker in Metastatic Colorectal Cancer Patients Receiving First-line Chemotherapy.
    Anticancer Res. 2018;38:4883-4888.
    PubMed     Text format     Abstract available

  5. ARAKAWA K, Hata K, Kawai K, Tanaka T, et al
    Predictors for High Microsatellite Instability in Patients with Colorectal Cancer Fulfilling the Revised Bethesda Guidelines.
    Anticancer Res. 2018;38:4871-4876.
    PubMed     Text format     Abstract available

  6. KARLBERG M, Stenstedt K, Hallstrom M, Ragnhammar P, et al
    Tumor Budding Versus Mismatch Repair Status in Colorectal Cancer - An Exploratory Analysis.
    Anticancer Res. 2018;38:4713-4721.
    PubMed     Text format     Abstract available

  7. SIM JJ, Park MH, Baek JH, Lee H, et al
    Investigation into Enhancing Capecitabine Efficacy in Colorectal Cancer by Inhibiting Focal Adhesion Kinase Signaling.
    Anticancer Res. 2018;38:4667-4676.
    PubMed     Text format     Abstract available

  8. KIM S, Park SG, Song YJ, Park JK, et al
    Analysis of Anticancer Activity and Chemical Sensitization Effects of Dendropanax morbifera and Commersonia bartramia Extracts.
    Anticancer Res. 2018;38:3853-3861.
    PubMed     Text format     Abstract available


    BMC Cancer

  9. CHIU KWH, Lam KO, An H, Cheung GTC, et al
    Long-term outcomes and recurrence pattern of 18F-FDG PET-CT complete metabolic response in the first-line treatment of metastatic colorectal cancer: a lesion-based and patient-based analysis.
    BMC Cancer. 2018;18:776.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  10. MORITA S, Kamimura K, Suda T, Oda C, et al
    Endoscopic ultrasound-guided transmural drainage for subphrenic abscess: report of two cases and a literature review.
    BMC Gastroenterol. 2018;18:55.
    PubMed     Text format     Abstract available


    Br J Cancer

  11. JUUL JS, Hornung N, Andersen B, Laurberg S, et al
    The value of using the faecal immunochemical test in general practice on patients presenting with non-alarm symptoms of colorectal cancer.
    Br J Cancer. 2018 Aug 1. pii: 10.1038/s41416-018-0178.
    PubMed     Text format     Abstract available


    Cancer Lett

  12. WU F, Liu F, Dong L, Yang H, et al
    miR-1273g silences MAGEA3/6 to inhibit human colorectal cancer cell growth via activation of AMPK signaling.
    Cancer Lett. 2018 Jul 26. pii: S0304-3835(18)30495.
    PubMed     Text format     Abstract available


    Eur J Cancer

  13. ARANDA E, Garcia Alfonso P, Benavides M, Sanchez Ruiz A, et al
    First-line mFOLFOX plus cetuximab followed by mFOLFOX plus cetuximab or single-agent cetuximab as maintenance therapy in patients with metastatic colorectal cancer: Phase II randomised MACRO2 TTD study.
    Eur J Cancer. 2018 Jul 24. pii: S0959-8049(18)30938.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  14. WU J, Wang F, Liu X, Zhang T, et al
    Correlation of IDH1 and B7H3 expression with prognosis of CRC patients.
    Eur J Surg Oncol. 2018;44:1254-1260.
    PubMed     Text format     Abstract available

  15. VAN HEINSBERGEN M, Janssen-Heijnen ML, Leijtens JW, Slooter GD, et al
    Bowel dysfunction after sigmoid resection underestimated: Multicentre study on quality of life after surgery for carcinoma of the rectum and sigmoid.
    Eur J Surg Oncol. 2018;44:1261-1267.
    PubMed     Text format     Abstract available

  16. CHINO A, Konishi T, Ogura A, Kawachi H, et al
    Endoscopic criteria to evaluate tumor response of rectal cancer to neoadjuvant chemoradiotherapy using magnifying chromoendoscopy.
    Eur J Surg Oncol. 2018;44:1247-1253.
    PubMed     Text format     Abstract available

  17. BLOK RD, Stam R, Westerduin E, Borstlap WAA, et al
    Impact of an institutional change from routine to highly selective diversion of a low anastomosis after TME for rectal cancer.
    Eur J Surg Oncol. 2018;44:1220-1225.
    PubMed     Text format     Abstract available

  18. MARIATHASAN AB, Boye K, Giercksky KE, Brennhovd B, et al
    Beyond total mesorectal excision in locally advanced rectal cancer with organ or pelvic side-wall involvement.
    Eur J Surg Oncol. 2018;44:1226-1232.
    PubMed     Text format     Abstract available


    Gastroenterology

  19. GOVERDE A, Wagner A, Bruno MJ, Hofstra RMW, et al
    Routine molecular analysis for Lynch syndrome among adenomas or colorectal cancer within a national screening program.
    Gastroenterology. 2018 Jul 28. pii: S0016-5085(18)34817.
    PubMed     Text format     Abstract available

  20. ENGEL C, Vasen HF, Seppala T, Aretz S, et al
    No Difference in Colorectal Cancer Incidence or Stage at Detection by Colonoscopy Among 3 Countries With Different Lynch Syndrome Surveillance Policies.
    Gastroenterology. 2018 Jul 28. pii: S0016-5085(18)34818.
    PubMed     Text format     Abstract available

  21. WIETEN E, de Klerk CM, van der Steen A, Ramakers CR, et al
    Equal Accuracy of 2 Quantitative Fecal Immunochemical Tests in Detecting Advanced Neoplasia in an Organized Colorectal Cancer Screening Program.
    Gastroenterology. 2018 Jul 25. pii: S0016-5085(18)34809.
    PubMed     Text format     Abstract available


    Hum Pathol

  22. KAWAMOTO S, Kamesaki T, Ryota Masutani MT, Kitao A, et al
    Ectopic expression of band 3 anion transport protein in colorectal cancer revealed in an autoimmune hemolytic anemia patient.
    Hum Pathol. 2018 Jul 28. pii: S0046-8177(18)30288.
    PubMed     Text format     Abstract available


    Int J Colorectal Dis

  23. SPONHOLZ S, Schirren M, Oguzhan S, Schirren J, et al
    Morbidity, mortality, and survival in elderly patients undergoing pulmonary metastasectomy for colorectal cancer.
    Int J Colorectal Dis. 2018 Jul 28. pii: 10.1007/s00384-018-3136.
    PubMed     Text format     Abstract available

  24. WANG P, Liang J, Zhou H, Wang Z, et al
    Extraperitoneal sigmoidostomy: a surgical approach with less complications and better functions for abdominoperineal resection of rectal cancer.
    Int J Colorectal Dis. 2018;33:41-46.
    PubMed     Text format     Abstract available

  25. WIRTH U, Rogers S, Haubensak K, Schopf S, et al
    Local antibiotic decontamination to prevent anastomotic leakage short-term outcome in rectal cancer surgery.
    Int J Colorectal Dis. 2018;33:53-60.
    PubMed     Text format     Abstract available

  26. QUINTANA JM, Anton-Ladislao A, Lazaro S, Gonzalez N, et al
    Outcomes of open versus laparoscopic surgery in patients with rectal cancer.
    Int J Colorectal Dis. 2018;33:99-103.
    PubMed     Text format     Abstract available

  27. PATEL R, Anderson JE, McKenzie C, Simpson M, et al
    Compliance with the 62-day target does not improve long-term survival.
    Int J Colorectal Dis. 2018;33:65-69.
    PubMed     Text format     Abstract available

  28. MAKOWIEC F, Bronsert P, Klock A, Hopt UT, et al
    Prognostic influence of hepatic margin after resection of colorectal liver metastasis: role of modern preoperative chemotherapy.
    Int J Colorectal Dis. 2018;33:71-78.
    PubMed     Text format     Abstract available


    Int J Oncol

  29. HUANG M, Geng Y, Deng Q, Li R, et al
    Translationally controlled tumor protein affects colorectal cancer metastasis through the high mobility group box 1-dependent pathway.
    Int J Oncol. 2018 Jul 25. doi: 10.3892/ijo.2018.4502.
    PubMed     Text format     Abstract available

  30. ZHOU L, Zhan ML, Tang Y, Xiao M, et al
    Effects of beta-caryophyllene on arginine ADP-ribosyltransferase 1-mediated regulation of glycolysis in colorectal cancer under high-glucose conditions.
    Int J Oncol. 2018 Jul 27. doi: 10.3892/ijo.2018.4506.
    PubMed     Text format     Abstract available

  31. LUCAS J, Hsieh TC, Halicka HD, Darzynkiewicz Z, et al
    Upregulation of PDL1 expression by resveratrol and piceatannol in breast and colorectal cancer cells occurs via HDAC3/p300mediated NFkappaB signaling.
    Int J Oncol. 2018 Aug 1. doi: 10.3892/ijo.2018.4512.
    PubMed     Text format     Abstract available

  32. KWAK B, Kim DU, Kim TO, Kim HS, et al
    MicroRNA-552 links Wnt signaling to p53 tumor suppressor in colorectal cancer.
    Int J Oncol. 2018 Jul 26. doi: 10.3892/ijo.2018.4505.
    PubMed     Text format     Abstract available

  33. CARRIERE PP, Kapur N, Mir H, Ward AB, et al
    Cinnamtannin B-1 inhibits cell survival molecules and induces apoptosis in colon cancer.
    Int J Oncol. 2018 Jul 19. doi: 10.3892/ijo.2018.4489.
    PubMed     Text format     Abstract available


    Lancet

  34. GEORGE AT, Aggarwal S, Dharmavaram S, Menon A, et al
    Regional variations in UK colorectal cancer screening and mortality.
    Lancet. 2018;392:277-278.
    PubMed     Text format    


    Oncol Rep

  35. CHENG K, Zhao Z, Wang G, Wang J, et al
    lncRNA GAS5 inhibits colorectal cancer cell proliferation via the miR1825p/FOXO3a axis.
    Oncol Rep. 2018 Jul 20. doi: 10.3892/or.2018.6584.
    PubMed     Text format     Abstract available

  36. NIE S, Huang Y, Shi M, Qian X, et al
    Protective role of ABCG2 against oxidative stress in colorectal cancer and its potential underlying mechanism.
    Oncol Rep. 2018 Jul 24. doi: 10.3892/or.2018.6594.
    PubMed     Text format     Abstract available

  37. JI B, Feng Y, Sun Y, Ji D, et al
    GPR56 promotes proliferation of colorectal cancer cells and enhances metastasis via epithelialmesenchymal transition through PI3K/AKT signaling activation.
    Oncol Rep. 2018 Jul 20. doi: 10.3892/or.2018.6582.
    PubMed     Text format     Abstract available


    PLoS One

  38. WOLFF A, Bayerlova M, Gaedcke J, Kube D, et al
    A comparative study of RNA-Seq and microarray data analysis on the two examples of rectal-cancer patients and Burkitt Lymphoma cells.
    PLoS One. 2018;13:e0197162.
    PubMed     Text format     Abstract available

  39. BOGACHEV MI, Volkov VY, Markelov OA, Trizna EY, et al
    Fast and simple tool for the quantification of biofilm-embedded cells sub-populations from fluorescent microscopic images.
    PLoS One. 2018;13:e0193267.
    PubMed     Text format     Abstract available

  40. KIM MJ, Hur BY, Lee ES, Park B, et al
    Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings.
    PLoS One. 2018;13:e0195815.
    PubMed     Text format     Abstract available

  41. BONNET E, Moutet ML, Baulard C, Bacq-Daian D, et al
    Performance comparison of three DNA extraction kits on human whole-exome data from formalin-fixed paraffin-embedded normal and tumor samples.
    PLoS One. 2018;13:e0195471.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: